Cargando…

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy

BACKGROUND: YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) has been indicated proven to participate in the cross-presentation of tumor antigens in dendritic cells and the cross-priming of CD8+ T cells. However, the role of YTHDF1 in prognosis and immunology in human cancers remains largely un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Jian, Qiu, Dongxu, Yu, Anze, Hu, Jiao, Deng, Hao, Li, Huihuang, Yi, Zhenglin, Chen, Jinbo, Zu, Xiongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134747/ https://www.ncbi.nlm.nih.gov/pubmed/34026603 http://dx.doi.org/10.3389/fonc.2021.607224

Ejemplares similares

Effects of Fibrin Clot Inhibitors and Statins on the Intravesical Bacille Calmette–Guérin Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis
por: Cai, Zhiyong, et al.
Publicado: (2021)

Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
por: Zhang, Chunyu, et al.
Publicado: (2021)

Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: a pooled analysis
por: Qiu, Dongxu, et al.
Publicado: (2020)

A Poliovirus Receptor (CD155)-Related Risk Signature Predicts the Prognosis of Bladder Cancer
por: Luo, Cong, et al.
Publicado: (2021)

RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
por: Li, Huihuang, et al.
Publicado: (2021)

N(6)-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
por: Quan, Chao, et al.
Publicado: (2021)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

miR-616-5p Promotes Invasion and Migration of Bladder Cancer via Downregulating NR2C2 Expression
por: Ren, Wenbiao, et al.
Publicado: (2021)

N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
por: Guo, Tao, et al.
Publicado: (2021)

Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis
por: Cheng, Chunliang, et al.
Publicado: (2021)

Adjuvant chemotherapy in patients with locally advanced bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a systematic review and pooled analysis
por: Cai, Zhiyong, et al.
Publicado: (2021)

Smoking status and pathological response to neoadjuvant chemotherapy among patients with bladder cancer: a pooled analysis
por: He, Tongchen, et al.
Publicado: (2021)

PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer
por: Qiu, Dongxu, et al.
Publicado: (2021)

Recurrence factors in patients with Keratinizing squamous metaplasia of the bladder after surgical management: a single-center retrospective study
por: Yi, Zhenglin, et al.
Publicado: (2021)

Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
por: He, Yunbo, et al.
Publicado: (2022)

5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
por: Hu, Jiao, et al.
Publicado: (2021)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022)

Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer
por: Hu, Jiao, et al.
Publicado: (2021)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Primary mucinous adenocarcinoma of the renal pelvis misdiagnosed as calculous pyonephrosis: a case report and literature review
por: Li, Huihuang, et al.
Publicado: (2020)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
por: Cai, Zhiyong, et al.
Publicado: (2022)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

Clinicopathological characteristics and survival outcomes for testicular choriocarcinoma: a population-based study
por: Li, Huihuang, et al.
Publicado: (2021)

Development and validation of a predictive nomogram for the risk of recurrence in patients with cystitis glandularis
por: Hu, Jiao, et al.
Publicado: (2020)

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
por: Yuan, Ziming, et al.
Publicado: (2023)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021)

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types
por: Hu, Ankang, et al.
Publicado: (2022)

Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8(+) T cell infiltration and functional transition
por: Yu, Anze, et al.
Publicado: (2023)

BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti‐PD‐1/PD‐L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity
por: Cai, Zhiyong, et al.
Publicado: (2023)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

Prognostic and predictive value of YTHDF1 and YTHDF2 and their correlation with tumor-infiltrating immune cells in non-small cell carcinoma
por: Koh, Young Wha, et al.
Publicado: (2022)

Prediction of clinically significant prostate cancer using a novel (68)Ga-PSMA PET-CT and multiparametric MRI-based model
por: Cheng, Chunliang, et al.
Publicado: (2023)

A pan-cancer analysis of ABI3BP: a potential biomarker for prognosis and immunoinfiltration
por: Feng, Yan, et al.
Publicado: (2023)

Comparison of clinical feasibility and oncological outcomes between video endoscopic and open inguinal lymphadenectomy for penile cancer: A systematic review and meta-analysis
por: Hu, Jiao, et al.
Publicado: (2019)

m(6)A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism
por: Liu, Peihua, et al.
Publicado: (2022)

Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma
por: Yan, Guanyu, et al.
Publicado: (2021)

Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker
por: Deng, Xinna, et al.
Publicado: (2023)

A preoperative nomogram predicting the pseudocapsule status in localized renal cell carcinoma
por: Hu, Jiao, et al.
Publicado: (2020)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_doob2a159k7ths98qjk185krok